Studyops, San Francisco, CA. 11/26/2014, and the Center for Occupational Health received an award for a new RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED Clinical Trial for patients with Fibromyalgia. Dr Viladimir Bokarius will be the lead principal investigator for the project, which will take place in our Richmond California location. Studyops continues to be the Sponsor's choice [...]
Studyops and Optimus, San Francisco, CA. were awarded 2 Studies for patients with HIV. Screening will begin in January. Check out www.studyops.com for our contact information to answer any questions. Please welcome Optimus, Dr. Shawn Hassler and his team to the Studyops family.
http://www.fiercepharma.com/story/takedas-us-chief-bows-out-amid-management-shake/2014-11-25?utm_medium=nl&utm_source=internal Takeda Chief is out, EVP Lise Kingo at Novo is out, Allergan pruning the Executive offices, plenty of others. All the M&A buys pipelines, but surely does not guarantee FDA follow through. www.studyops.com
Karla Burke Life Sciences Senior Marketing Specialist at Thomson ReutersTop Contributor Leading health experts said that having decided it is ethical to use non-approved products to help deal with the Ebola virus epidemic, it would be unethical if those drugs were administered in the context of randomized clinical trials. “No one insisted Western medical workers [...]
With the Ebola virus becoming a major global healthcare crisis, Quorum Review IRB recognizes the imperative nature for developing new vaccines and treatments quickly. To assist investigators, medical institutions, as well as pharmaceutical sponsors and CROs, we are offering initial board review for Phase I Ebola studies at NO CHARGE. http://us1.campaign-archive1.com/?u=75cdd3197c4f2f278789c2b54&id=fe3bcb24d8&e=728640ad3b
http://finance.yahoo.com/news/fda-approves-hard-abuse-hydrocodone-pill-181653518--finance.html
Photographer: Mohamed Hossam/Anadolu Agency/Getty Images In India, perhaps Ground Zero in the sanitation and faecal contamination battle, the government has set Mahatma Gandhi’s 150th birthday in 2019 as its target for achieving “total sanitation,” including access to toilets for all 1.2 billion residents. In a world in which 14 percent of the population in the [...]
The world spends most of its money on medicine. New study reveals that by the year 2018 the world drug bill will reach approximately $1.3 trillion. The new treatments for cancer and hepatitis C contribute to the rise. Another factor for this increase are the people that buy pharmaceuticals using their rising incomes. The new [...]
Gilead's ($GILD) hep C wonder combo, Harvoni, boasts cure rates as high as 99.1%, and analysts have said they expect it to rack up $10 billion a year in sales, becoming the fastest-growing drug of all time on the way there. But if all of that's the case, then why are U.S. scripts lagging [...]
Merck (NYSE:MRK) cholesterol drug Vytorin, an ezetimibe-simvastatin combo, successfully cuts the risk of heart attacks and strokes in high-risk patients more than simvastatin alone, said the drugmaker in its nearly decade-long, 18,144-patient study. Read More At Investor's Business Daily: http://news.investors.com/technology/111714-726775-merck-vytorin-cholesterol-drug-study-successful.htm#ixzz3JWnjutCg Follow us: @IBDinvestors on Twitter | InvestorsBusinessDaily on Facebook
